2170 Results

People

  1. Busam
    Busam
  2. Marghoob
    Marghoob
  3. Halpern
    Halpern
  4. Houghton
    Houghton
  5. Coit
    Coit
  6. Wolchok
    Wolchok
  7. Old
    Old
  8. Chapman
    Chapman
  9. Postow
    Postow
  10. Dusza
    Dusza

Groups

  1. Department of Medicine (1009)
  2. Melanoma Disease Management Team (710)
  3. Solid Tumor Oncology Division (575)
  4. Survivorship Research (510)
  5. Division of Subspecialty Medicine (420)
  6. GSK Faculty (404)
  7. Dermatology (393)
  8. Dermatology Service (387)
  9. Melanoma and Immunotherapeutics Service (380)
  10. Population Sciences Research Program (361)
  1. "melanoma"
Formats
  1. Journal Article (1939)
  2. Review (86)
  3. Editorial (32)
  4. Research Letter (28)
  5. Book Section (27)
  6. Conference Paper (19)
  7. Meeting Abstract (12)
  8. Guidelines (11)
  9. Miscellaneous (9)
  10. Correspondence (7)
Groups
  1. Department of Medicine (1009)
  2. Melanoma Disease Management Team (710)
  3. Solid Tumor Oncology Division (575)
  4. Survivorship Research (510)
  5. Division of Subspecialty Medicine (420)
  6. GSK Faculty (404)

More Groups

People
  1. Klaus Busam (217)
  2. Ashfaq Marghoob (212)
  3. Jedd Wolchok (180)
  4. Allan Halpern (153)
  5. Alan Houghton (138)
  6. Paul Chapman (125)

More People

Years
  1. 2025 (48)
  2. 2024 (94)
  3. 2023 (92)
  4. 2022 (94)
  5. 2021 (63)
  6. 2020 (76)

More Years

Publications
  1. Journal of the American Academy of Dermatology (89)
  2. Annals of Surgical Oncology (65)
  3. Journal of Clinical Oncology (65)
  4. Clinical Cancer Research (56)
  5. Cancer Research (48)
  6. Cancer (45)

More Publications

Publishers
  1. Elsevier Inc. (206)
  2. Springer (184)
  3. Wiley Blackwell (173)
  4. Lippincott Williams & Wilkins (166)
  5. American Association for Cancer Research (141)
  6. Mosby Elsevier (95)

More Publishers

Results (2170)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Are the MIA and MSKCC nomograms useful in selecting patients with melanoma for sentinel lymph node biopsy?
    Journal Article

    Hosein, S.; Drebin, H. M.; Kurtansky, N. R.; Olofsson Bagge, R.; Coit, D. G.; Bartlett, E. K.; Marchetti, M. A.
    Journal of Surgical Oncology (2023)

    Fulltext@MSK | Save
  • Development and implementation of an interdisciplinary telemedicine clinic for older patients with cancer—Preliminary data
    Journal Article

    Alexander, K.; Hamlin, P. A.; Tew, W. P.; Trevino, K.; Tin, A. L.; Shahrokni, A.; Meditz, E.; Boparai, M.; Amirnia, F.; Sun, S. W.; more...
    Journal of the American Geriatrics Society (2023)

    Fulltext@MSK | Save
  • The impact of immunosuppressive agents on immune checkpoint inhibitor efficacy in patients with advanced melanoma: A real-world, multicenter, retrospective study
    Journal Article

    Lev-Ari, S.; Serzan, M.; Wu, T.; Ip, A.; Pascual, L.; Sinclaire, B.; Adams, S.; Marafelias, M.; Ayyagari, L.; Gill, S. K.; more...
    Cancer (2023)

    Fulltext@MSK | Save
  • Does stage migration occur as a consequence of omitting completion lymph node dissection for melanoma?
    Journal Article

    Senders, Z. J.; Bartlett, E. K.; Mouw, T. J.; McMasters, K. M.; Egger, M. E.
    Annals of Surgical Oncology (2023)

    Fulltext@MSK | Save
  • Methylation of nonessential genes in cutaneous melanoma - Rule Out hypothesis
    Journal Article

    Gorlov, I. P.; Conway, K.; Edmiston, S. N.; Parrish, E. A.; Hao, H.; Amos, C. I.; Tsavachidis, S.; Gorlova, O. Y.; Begg, C.; Hernando, E.; more...
    Melanoma Research (2023)

    Fulltext@MSK | Save
  • Nivolumab and relatlimab in patients with advanced melanoma that had progressed on anti-programmed death-1/programmed death ligand 1 therapy: Results from the phase I/IIa RELATIVITY-020 trial
    Journal Article

    Ascierto, P. A.; Lipson, E. J.; Dummer, R.; Larkin, J.; Long, G. V.; Sanborn, R. E.; Chiarion-Sileni, V.; Dréno, B.; Dalle, S.; Schadendorf, D.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Early detection and prognostic assessment of cutaneous melanoma: Consensus on optimal practice and the role of gene expression profile testing
    Review

    Kashani-Sabet, M.; Leachman, S. A.; Stein, J. A.; Arbiser, J. L.; Berry, E. G.; Celebi, J. T.; Curiel-Lewandrowski, C.; Ferris, L. K.; Grant-Kels, J. M.; Grossman, D.; more...
    JAMA Dermatology (2023)

    Fulltext@MSK | Save
  • ASO Visual Abstract: Does stage migration occur as a consequence of omitting completion lymph node dissection for melanoma?
    Miscellaneous

    Senders, Z. J.; Bartlett, E. K.; Mouw, T. J.; McMasters, K. M.; Egger, M. E.
    Annals of Surgical Oncology (2023)

    Fulltext@MSK | Save
  • Therapeutic targeting of PRAME with m(TCR)CAR T cells in acute myeloid leukemia
    Journal Article

    Kirkey, D. C.; Loeb, A. M.; Castro, S.; McKay, C. N.; Perkins, L.; Pardo, L.; Leonti, A. R.; Tang, T. T.; Loken, M. R.; Brodersen, L. E.; more...
    Blood Advances (2023)

    Fulltext@MSK | Save
  • InterMEL: An international biorepository and clinical database to uncover predictors of survival in early-stage melanoma
    Journal Article

    Orlow, I.; Sadeghi, K. D.; Edmiston, S. N.; Kenney, J. M.; Lezcano, C.; Wilmott, J. S.; Cust, A. E.; Scolyer, R. A.; Mann, G. J.; Lee, T. K.; more...
    PLoS ONE (2023)

    Fulltext@MSK | Save